- Home
- FGEN vs SCOR Comparison
FGEN vs SCOR Comparison
Compare FGEN & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- SCOR
- Stock Information
- Founded
- FGEN 1993
- SCOR 1999
- Country
- FGEN United States
- SCOR United States
- Employees
- FGEN N/A
- SCOR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- SCOR Business Services
- Sector
- FGEN Health Care
- SCOR Consumer Discretionary
- Exchange
- FGEN Nasdaq
- SCOR Nasdaq
- Market Cap
- FGEN 38.4M
- SCOR 34.6M
- IPO Year
- FGEN 2014
- SCOR 2007
- Fundamental
- Price
- FGEN $11.51
- SCOR $6.41
- Analyst Decision
- FGEN Strong Buy
- SCOR
- Analyst Count
- FGEN 2
- SCOR 0
- Target Price
- FGEN $146.50
- SCOR N/A
- AVG Volume (30 Days)
- FGEN 52.1K
- SCOR 7.6K
- Earning Date
- FGEN 11-11-2025
- SCOR 11-11-2025
- Dividend Yield
- FGEN N/A
- SCOR N/A
- EPS Growth
- FGEN N/A
- SCOR N/A
- EPS
- FGEN N/A
- SCOR N/A
- Revenue
- FGEN $7,346,000.00
- SCOR $358,513,000.00
- Revenue This Year
- FGEN N/A
- SCOR $3.45
- Revenue Next Year
- FGEN N/A
- SCOR $2.59
- P/E Ratio
- FGEN N/A
- SCOR N/A
- Revenue Growth
- FGEN N/A
- SCOR N/A
- 52 Week Low
- FGEN $4.50
- SCOR $4.39
- 52 Week High
- FGEN $21.94
- SCOR $8.99
- Technical
- Relative Strength Index (RSI)
- FGEN 56.57
- SCOR 51.69
- Support Level
- FGEN $11.12
- SCOR N/A
- Resistance Level
- FGEN $12.53
- SCOR $6.92
- Average True Range (ATR)
- FGEN 0.86
- SCOR 0.18
- MACD
- FGEN -0.11
- SCOR -0.28
- Stochastic Oscillator
- FGEN 52.40
- SCOR 91.97
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.